Back
Acumen Pharmaceuticals Stock Price Chart
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
36
ABOS
Acumen Pharmaceuticals
Last Price:
3.48
Seasonality Move:
68.9%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- The current trend is relatively stagnant and ABOS is experiencing slight selling pressure.
Acumen Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.18 | Buy |
| 20-day SMA: | 3.45 | Sell |
| 50-day SMA: | 3.84 | Sell |
| 200-day SMA: | 4.14 | Sell |
| 8-day EMA: | 3.24 | Buy |
| 20-day EMA: | 3.42 | Sell |
| 50-day EMA: | 3.6 | Sell |
| 200-day EMA: | 4.01 | Sell |
Acumen Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 38.06 | Sell |
| Chaikin Money Flow: | -12691 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.22 - 3.9) | Sell |
| Bollinger Bands (100): | (3.13 - 4.11) | Sell |
Acumen Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Acumen Pharmaceuticals Stock
Is Acumen Pharmaceuticals Stock a Buy?
- Acumen Pharmaceuticals share price is 3.25 while ABOS 8-day simple moving average is 3.18, which is a Buy signal.
- The stock price of ABOS is 3.25 while Acumen Pharmaceuticals 20-day SMA is 3.45, which makes it a Sell.
- Acumen Pharmaceuticals 50-day simple moving average is 3.84 while ABOS share price is 3.25, making it a Sell technically.
- ABOS stock price is 3.25 and Acumen Pharmaceuticals 200-day simple moving average is 4.14, creating a Sell signal.
ABOS Technical Analysis vs Fundamental Analysis
Sell
36
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy or a Sell?
-
Acumen Pharmaceuticals stock is rated a Sell
The current Acumen Pharmaceuticals [ABOS] share price is $3.25. The Score for ABOS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Acumen Pharmaceuticals Stock Info
Market Cap:
195.26M
Price in USD:
3.25
Share Volume:
190.37K
Acumen Pharmaceuticals 52-Week Range
52-Week High:
11.31
52-Week Low:
1.81
Sell
36
Acumen Pharmaceuticals (ABOS)
is a Sell
Acumen Pharmaceuticals Share Price Forecast
-
What is the Acumen Pharmaceuticals stock price today?
The Acumen Pharmaceuticals stock price is 3.25 USD today. -
Will ABOS stock go up or go down?
Acumen Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Acumen Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acumen Pharmaceuticals is overvalued.
Is Acumen Pharmaceuticals Stock a Buy?
- Acumen Pharmaceuticals share price is 3.25 while ABOS 8-day exponential moving average is 3.24, which is a Buy signal.
- The stock price of ABOS is 3.25 while Acumen Pharmaceuticals 20-day EMA is 3.42, which makes it a Sell.
- Acumen Pharmaceuticals 50-day exponential moving average is 3.60 while ABOS share price is 3.25, making it a Sell technically.
- ABOS stock price is 3.25 and Acumen Pharmaceuticals 200-day simple moving average is 4.01, creating a Sell signal.
Fundamental Analysis of Acumen Pharmaceuticals
Is Acumen Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Acumen Pharmaceuticals
Should I short Acumen Pharmaceuticals stock?
- ABOS Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Acumen Pharmaceuticals is a Sell
- Acumen Pharmaceuticals Relative Strength Index (RSI) is 38.06, which suggest Acumen Pharmaceuticals is oversold
- The Bollinger Bands (25) for Acumen Pharmaceuticals is (3.22 - 3.9), which suggest Acumen Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Acumen Pharmaceuticals is (3.13 - 4.11), which suggest Acumen Pharmaceuticals is a Sell
* Acumen Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.